Select Page

The global array instruments market is expected to register a CAGR of around 9% during 2025, according to a new report published by IMARC Group. Array instruments are devices that are used to collect microscopic spots of RNA, DNA, proteins, tissues, peptides, oligonucleotides, cells, and other compounds attached to a solid substrate. They are utilized in laboratories that quantitatively and simultaneously monitor the expression of multiple genes. The high-throughput approach of array technology helps to locate mutations and chromosomal expressions in a genotype, and measure and detect gene expressions at the messenger RNA (mRNA) or the protein level.

Request for a free sample copy of this report:

Market Trends

The primary factors driving the array instruments market are the emerging need for diagnosing cancer, post-natal and different metabolic diseases. These instruments assist in hybridization, coupling biomolecules to a platform, sample preparation for detection, data analysis, and scanning, which have increased their demand in recent times. Furthermore, governments across the globe have undertaken several initiatives to improve the healthcare infrastructure and increase investments in research and development (R&D) activities, which in turn have boosted the demand for array instruments. Moreover, the introduction of the latest technologies, such as microarray-based comparative genomic hybridization, has enhanced the process of single nucleotide polymorphism (SNP) and offers accuracy and precision in disease diagnosis and drug discovery, which in turn is expected to provide a positive impact on the industry.

Competitive Landscape

The report has also examined the competitive landscape of global array instruments market.

Affymetrix Inc.
Agilent Technologies Inc. (NYSE: A)
Arrayit Corporation (OTCMKTS: ARYC)
Bio-RAD Laboratories (NYSE: BIO)
Illumina Inc. (NASDAQ: ILMN)
Laboratory Corporation (NYSE: LH)
Molecular Devices LLC
Raybiotech Inc.
Sigma Aldrich Corporation
Thermo Fisher Scientific Inc. (NYSE: TMO)

Key Segments of the Report:

Breakup by Application:

Molecular Biology
Cell Biology
Molecular Pathology

Breakup by Technology:

DNA Microarrays
Protein Microarrays
Cellular Microarrays
Tissue Microarrays

Explore full report with table of contents:
Breakup by End-User:

Research and Development Laboratories
Clinical Diagnostic Labs
Agriculture Research Centers
Veterinary Laboratories
Forensic Centers

Breakup by Region:

North America
United States
Asia Pacific
South Korea
United Kingdom
Latin America
Middle East and Africa

Key highlights of the report:

Market Performance
Market Outlook
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Competitive Structure
Profiles of Key Players

Browse Related Report:

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:
30 N Gould St, Ste R
Sheridan, WY 82801, USA
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal